Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging

NCT00208299 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00208299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00208299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
August 31, 2006
Enrollment
1,231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease